- OptimizeRx (NASDAQ:OPRX) secured two new SaaS-based enterprise-level engagements providing full spectrum access to its nationwide digital healthcare platform and taking total contract wins to six in 2020.
- With both the deals having annual average contract value of $3.6M, one is a new platform client and the other is the transition of a legacy client to the company's new enterprise solution suite.
- "We are encouraged by the continued conversion of our pipeline of enterprise-level opportunities and the resulting buildup in recurring revenue," CEO William Febbo commented.
- The company's up-sell opportunity for converting legacy clients from individual solutions to enterprise platform engagements remains $100M+.